QIAGEN Aktie

37,34EUR 0,65EUR 1,76%
QIAGEN für 0 Euro bei ZERO ordern (zzgl. Spreads)
WKN DE: A40ZZU / ISIN: NL0015002CX3
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>

Personal

2020 2021 2022 2023 2024
Personal am Ende des Jahres 5 610 6 028 6 178 5 967 0
Umsatz pro Mitarbeiter in Mio. EUR 0,33 0,37 0,35 0,33 0,00

Bilanz (in Mio. USD) - Aktiva

2020 2021 2022 2023 2024
Summe Umlaufvermögen 1 667 2 110 2 394 2 148 1 960
Summe Anlagevermögen 4 245 4 037 3 894 3 968 3 730
Summe Aktiva 5 913 6 147 6 288 6 115 5 690

Bilanz (in Mio. USD) - Passiva

2020 2021 2022 2023 2024
Summe Fremdkapital 3 115 3 050 2 821 2 307 2 122
Summe Eigenkapital 2 798 3 097 3 467 3 808 3 567
Summe Passiva 5 913 6 147 6 288 6 115 5 690

Adresse

Hulsterweg 82, 5912 PL Venlo
Telefon +31 (77) 355-66-00
Internet http://www.qiagen.com

Management

Antonio Santos
Senior Vice President & Head-Global Operations
Bert van Meurs
Member-Supervisory Board
Elaine R. Mardis
Member-Supervisory Board
Elizabeth E. Tallett
Member-Supervisory Board
Eva Pisa
Member-Supervisory Board
Eva van Pelt
Member-Supervisory Board
Jean-Pascal Viola
SVP, Head-Strategy & Business Development
John Gilardi
Head-Investor Relations & Corporate Communications
Jonathan G. Sheldon
Senior VP-Digital Insights Business Area
Lawrence A. Rosen
Chairman-Supervisory Board
Lezette Young
Manager-Global Compliance
Metin Colpan
Member-Supervisory Board
Nedal Safwat
VP & Head-Molecular Diagnostics North America
Philipp von Hugo
VP, Head-Global Legal Affairs & Compliance
Roland Sackers
Chief Financial Officer & Managing Director
Ross L. Levine
Member-Supervisory Board
Stephany Foster
Senior Vice President & Head-Human Resources
Stephen H. Rusckowski
Member-Supervisory Board
Thierry Bernard
Chief Executive Officer & Managing Director
Thomas Theuringer
Senior Director-Corporate Communications
Toralf Haag
Member-Supervisory Board